Roberta M. Tankanow

1.1k total citations
25 papers, 801 citations indexed

About

Roberta M. Tankanow is a scholar working on Geriatrics and Gerontology, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roberta M. Tankanow has authored 25 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 4 papers in General Health Professions and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roberta M. Tankanow's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Trace Elements in Health (3 papers) and Glioma Diagnosis and Treatment (3 papers). Roberta M. Tankanow is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Trace Elements in Health (3 papers) and Glioma Diagnosis and Treatment (3 papers). Roberta M. Tankanow collaborates with scholars based in United States and India. Roberta M. Tankanow's co-authors include Karen J. Kluin, George J. Brewer, A. B. Young, Robert D. Dick, David Dickinson, L. McCormick, Margaret Ross, Inta J. Ertel, Robert Dick and Matthew T. Lorincz and has published in prestigious journals such as Neurology, Journal of neurosurgery and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Roberta M. Tankanow

23 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta M. Tankanow United States 14 335 192 161 141 100 25 801
Ewan Cameron United Kingdom 16 1.4k 4.3× 112 0.6× 370 2.3× 69 0.5× 47 0.5× 29 2.1k
Premila Abraham India 23 97 0.3× 29 0.2× 221 1.4× 92 0.7× 91 0.9× 53 1.2k
Semra Şardaş Türkiye 22 48 0.1× 291 1.5× 420 2.6× 121 0.9× 85 0.8× 90 1.5k
G.D. Sweeney Canada 21 81 0.2× 308 1.6× 484 3.0× 48 0.3× 106 1.1× 49 1.4k
Martin Béliveau United States 18 82 0.2× 60 0.3× 180 1.1× 34 0.2× 61 0.6× 29 942
Begoña Manuel‐y‐Keenoy Belgium 19 169 0.5× 68 0.4× 178 1.1× 45 0.3× 26 0.3× 35 1.1k
Naoko Tsugawa Japan 25 1.2k 3.4× 55 0.3× 361 2.2× 21 0.1× 133 1.3× 92 2.4k
Azza A. K. El‐Sheikh Egypt 22 100 0.3× 56 0.3× 447 2.8× 78 0.6× 412 4.1× 77 1.8k
Priyadarshani Galappatthy Sri Lanka 11 388 1.2× 149 0.8× 74 0.5× 72 0.5× 39 0.4× 36 846
R. A. Smallwood Australia 19 155 0.5× 70 0.4× 91 0.6× 35 0.2× 237 2.4× 43 934

Countries citing papers authored by Roberta M. Tankanow

Since Specialization
Citations

This map shows the geographic impact of Roberta M. Tankanow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta M. Tankanow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta M. Tankanow more than expected).

Fields of papers citing papers by Roberta M. Tankanow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta M. Tankanow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta M. Tankanow. The network helps show where Roberta M. Tankanow may publish in the future.

Co-authorship network of co-authors of Roberta M. Tankanow

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta M. Tankanow. A scholar is included among the top collaborators of Roberta M. Tankanow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta M. Tankanow. Roberta M. Tankanow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sweet, Burgunda V., et al.. (2008). Improving investigational drug service operations through development of an innovative computer system. American Journal of Health-System Pharmacy. 65(10). 969–973. 7 indexed citations
2.
Brewer, George J., Fred Askari, Matthew T. Lorincz, et al.. (2007). Tetrathiomolybdate versus Trientine in the Initial Treatment of Neurologic Wilson's Disease. 3(1). 1 indexed citations
3.
Brewer, George J., Fred Askari, Matthew T. Lorincz, et al.. (2006). Treatment of Wilson Disease With Ammonium Tetrathiomolybdate. Archives of Neurology. 63(4). 521–521. 207 indexed citations
4.
Tankanow, Roberta M., Daniel S. Streetman, Scott Smith, et al.. (2003). Interaction Study between Digoxin and a Preparation of Hawthorn [Crataegus oxyacantha]. The Journal of Clinical Pharmacology. 43(6). 637–642. 24 indexed citations
5.
Tankanow, Roberta M., Daniel S. Streetman, Scott Smith, et al.. (2003). Interaction Study between Digoxin and a Preparation of Hawthorn (Crataegus oxyacantha). The Journal of Clinical Pharmacology. 43(6). 637–642. 45 indexed citations
6.
Siden, Rivka, et al.. (2002). Understanding and preparing for clinical drug trial audits. American Journal of Health-System Pharmacy. 59(23). 2301–2301. 5 indexed citations
7.
Tankanow, Roberta M.. (1998). Docetaxel: A taxoid for the treatment of metastatic breast cancer. American Journal of Health-System Pharmacy. 55(17). 1777–1791. 21 indexed citations
8.
Tankanow, Roberta M., et al.. (1994). Corticosteroids in the management of alcoholic hepatitis. American Journal of Health-System Pharmacy. 51(3). 347–353. 2 indexed citations
9.
Greenberg, H. S., William F. Chandler, W D Ensminger, et al.. (1994). Radiosensitization with carotid intra‐arterial bromodeoxyuridine ± 5‐fluorouracil biomodulation for malignant gliomas. Neurology. 44(9). 1715–1715. 15 indexed citations
10.
Tankanow, Roberta M., et al.. (1992). Patients' perceived understanding of informed consent in investigational drug studies. American Journal of Health-System Pharmacy. 49(3). 633–635. 8 indexed citations
11.
Tankanow, Roberta M., et al.. (1992). Patients' perceived understanding of informed consent in investigational drug studies.. PubMed. 49(3). 633–5. 16 indexed citations
12.
Tankanow, Roberta M., et al.. (1991). Ondansetron--the first of a new class of antiemetic agents.. PubMed. 10(6). 430–46. 19 indexed citations
13.
Tankanow, Roberta M., et al.. (1991). Ondansetron—the first of a new class of antiemetic agents. American Journal of Health-System Pharmacy. 48(7). 1593–1609. 2 indexed citations
14.
Brewer, George J., et al.. (1991). Initial Therapy of Patients With Wilson's Disease With Tetrathiomolybdate. Archives of Neurology. 48(1). 42–47. 162 indexed citations
15.
Thornton, Allan F., William F. Chandler, William D. Ensminger, et al.. (1990). Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas. International Journal of Radiation Oncology*Biology*Physics. 19(2). 421–428. 41 indexed citations
16.
Tankanow, Roberta M., et al.. (1990). A Double-Blind, Placebo-Controlled Study of the Efficacy of Lactinex in the Prophylaxis of Amoxicillin-Induced Diarrhea. DICP. 24(4). 382–384. 107 indexed citations
17.
Kirking, Duane M., et al.. (1989). Investigational drug practices in Michigan hospitals. American Journal of Health-System Pharmacy. 46(7). 1370–1375. 3 indexed citations
18.
Greenberg, Harry S., William F. Chandler, William D. Ensminger, et al.. (1988). Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas. Journal of neurosurgery. 69(4). 500–505. 31 indexed citations
19.
Tankanow, Roberta M., et al.. (1988). Comparison of famotidine with cimetidine and ranitidine.. PubMed. 7(4). 271–84. 29 indexed citations
20.
Cook, Jack, et al.. (1988). Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure. Clinical Pharmacology & Therapeutics. 44(5). 487–500. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ewan Cameron Breakdown of academic impact, for papers by Premila Abraham Breakdown of academic impact, for papers by Semra Şardaş Breakdown of academic impact, for papers by G.D. Sweeney Breakdown of academic impact, for papers by Martin Béliveau Breakdown of academic impact, for papers by Begoña Manuel‐y‐Keenoy Breakdown of academic impact, for papers by Naoko Tsugawa Breakdown of academic impact, for papers by Azza A. K. El‐Sheikh Breakdown of academic impact, for papers by Priyadarshani Galappatthy Breakdown of academic impact, for papers by R. A. Smallwood
Rankless by CCL
2026